Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record for IDL-2965 is displayed with its purpose, trial design, participant criteria, outcome measures, and study dates. It also shows that the trial was terminated and is no longer recruiting participants.SummaryDifference40%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a terminology transition.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedRemoval of the 403 error page fragment, including the HTML header and Home link, indicating that the error page artifacts were deleted and the page now presents standard site content.SummaryDifference0.5%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.